Document is current
Any future updates will be listed below
-
Authors
Li, Chia-Chun
Ou, Ling-Chun
Chang, Yin-Fan
Chang, Chin-Sung
Sun, Zih-Jie
Cheng, Tien-Tsai
Kuo, Li-Chieh
Wu, Chih-Hsing https://orcid.org/0000-0002-0504-2053
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 108-2314-B-006-043-MY2)
Ministry of Science and Technology, Taiwan (MOST 110-2314-B-006-054-MY2)
National Science and Technology Council (NSTC112-2314-B-006-023-MY3)
National Cheng Kung University Hospital (T11203027)
National Cheng Kung University Hospital (T11303042)
National Cheng Kung University Hospital (T11203057)
National Cheng Kung University Hospital (T11303017)
- License Information
-
More Information
Article History
Received: 4 November 2024
Accepted: 2 August 2025
First Online: 20 August 2025
Declarations
:
: Chia-Chun Li, Ling-Chun Ou, Yin-Fan Chang, Chin-Sung Chang, Zih-Jie Sun, Tien-Tsai Cheng, and Li-Chieh Kuo declare no conflicts of interest. Chih-Hsing Wu: honoraria for lectures, attending meetings, research grant or travel from Eli Lilly, Novartis, Roche, Abbott, Pfizer, Boehringer, Bayers, Takeda, Merck, Sanofi-Aventis, GlaxoSmithKline, Servier laboratories, GE Lunar, Schering-Plough, Harvester, TCM Biotch, Alvogen/Lotus, Teijin Pharma, Amgen, Der-Zeng, Sankyo Daiichi, Alnylam, and AstraZeneca.
